SILO PHARMA, INC. Remaining Share Repurchase Authorization
SILO PHARMA, INC. (SILO) had Remaining Share Repurchase Authorization of $1.00 million as of 2024-04-04, per its 10-Q filed 2024-05-13.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2024-05-13
- 2024-04-04: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.00M.
- 2024-01-09: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.00M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2024-04-04 | $1.00M 10-Q · filed 2024-05-13 |
| 2024-01-09 | $1.00M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |